Clinical Study
Clinical Outcomes of Colonic Stent in a Tertiary Care Center
Table 1
Baseline patient characteristics
.
| | Variables | Numbera |
| | Age in years (±SD) | 70.88 (±20) | | Female gender | 9 (56.25%) | | Admission status | | | Inpatient | 12 (75%) | | Same day procedure | 4 (25%) | | Most common obstructive symptom | | | Constipation | 5 (31.3%) | | Bloating | 4 (25%) | | Overflow diarrhea | 1 (6.2%) | | Nausea ± vomiting | 4 (25%) | | Abdominal pain | 2 (12.5%) | | Obstruction confirmed by imaging prior to stenting | | | Colonic barium enema | 2 (12.5%) | | CT abdomen/pelvis | 11 (68.8%) | | None | 3 (18.7%) | | Duration of symptoms (±SD) | 12.8 (±9.8) | | Malignancy type | | | Primary colon adenocarcinoma | 7 (43.8%) | | Recurrent colon adenocarcinoma | 2 (12.5%) | | Ovarian adenocarcinoma | 3 (18.7%) | | Pancreatic adenocarcinoma | 2 (12.5%) | | Others | 2 (12.5%) | | Presence of known metastases | 12 (75%) | | Site of metastases | | | Liver | 3 (25%) | | Lung | 1 (8.3%) | | Both liver and lung | 2 (16.7%) | | Peritoneum | 5 (41.7%) | | Lymph node | 1 (8.3%) | | Site of obstruction | | | Ascending colon and hepatic flexure | 1 (6.2%) | | Transverse colon | 1 (6.2%) | | Descending and splenic flexure | 5 (31.3%) | | Rectosigmoid | 9 (56.3%) | | Type of occlusion | | | Partial | 11 (68.8%) | | Complete | 5 (31.3%) | | Compression type | | | Intrinsic | 11 (68.7%) | | Extrinsic | 5 (31.3%) | | Deemed fit for surgery | | | Yes | 3 (18.7%) | | No | 13 (81.3%) | | Chemotherapy before stent placement | 9 (56.3%) | | Chemotherapy after stent placement | 7 (43.7%) | | Charlson comorbidity index (mean ± SD) | 8.25 (±2) |
|
|
Values are represented as (%) for categorical variables and mean (±SD) for continuous variables.
|
